These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8791242)

  • 1. Study of lower limb somatosensory evoked potentials in 96 cases of HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Moritoyo H; Arimura K; Arimura Y; Tokimura Y; Rosales R; Osame M
    J Neurol Sci; 1996 Jun; 138(1-2):78-81. PubMed ID: 8791242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor and somatosensory evoked potential findings in HTLV-I associated myelopathy.
    Suga R; Tobimatsu S; Kira J; Kato M
    J Neurol Sci; 1999 Aug; 167(2):102-6. PubMed ID: 10521547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and physiological significance of abnormally prolonged central motor conduction time in HAM/TSP.
    Shimizu H; Shiga Y; Fujihara K; Ohnuma A; Itoyama Y
    J Neurol Sci; 2001 Mar; 185(1):39-42. PubMed ID: 11266689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological functions of the ascending spinal tracts in HTLV-I-associated myelopathy (HAM).
    Kakigi R; Kuroda Y; Takashima H; Endo C; Neshige R; Shibasaki H
    Electroencephalogr Clin Neurophysiol; 1992; 84(2):110-4. PubMed ID: 1372225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HTLV-I seronegative idiopathic progressive spastic paraparesis: clinical and neurophysiological study of the sensory features].
    Castillo JL; Cea G; Cartier L; Verdugo R
    Rev Med Chil; 2001 Jul; 129(7):735-41. PubMed ID: 11552441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Somatosensitive and motor evoked potentials in HTLV-I associated myelopathy].
    Andrade DO
    Arq Neuropsiquiatr; 2005 Sep; 63(3A):652-5. PubMed ID: 16172717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evoked potential abnormalities in progressive spastic paraparesis associated to HTLV-1.
    Castillo JL; Cartier L; Araya F; Verdugo R; Mora C; Gibbs C
    Acta Neurol Scand; 1991 Mar; 83(3):151-4. PubMed ID: 2031447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tropical spastic paraparesis (HAM/TSP) in different regions of the world. Subclinical and geographic differences in neurophysiologic studies].
    León-S FE; Zaninovic V; Osame M; Arimura K; Arimura Y
    Rev Med Chil; 1994 Mar; 122(3):265-73. PubMed ID: 7809516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): A comparative study to identify factors that influence disease progression.
    Matsuura E; Nozuma S; Tashiro Y; Kubota R; Izumo S; Takashima H
    J Neurol Sci; 2016 Dec; 371():112-116. PubMed ID: 27871430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensory dysfunction in HTLV-I-associated myelopathy/tropical spastic paraparesis. A comprehensive neurophysiological study.
    Castillo JL; Cea JG; Verdugo RJ; Cartier L
    Eur Neurol; 1999 Jul; 42(1):17-22. PubMed ID: 10394043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor pathway analysis in HAM/TSP using magnetic stimulation and F-waves.
    Young RE; Morgan OS; Forster A
    Can J Neurol Sci; 1998 Feb; 25(1):48-54. PubMed ID: 9532281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Electroneuromyography and somatosensory evoked potentials in HTLV-I associated myelopathy].
    Cruz MW; Corrêa RB; Puccioni-Sohler M; Novis SA
    Arq Neuropsiquiatr; 1998 Dec; 56(4):756-62. PubMed ID: 10029878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Yamano Y; Sato T
    Nihon Rinsho; 2013 May; 71(5):870-5. PubMed ID: 23777097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients.
    Ghezeldasht SA; Sadeghian H; Azarpazhooh MR; Shamsian SAA; Rafatpanah H; Mahmoodi M; Rezaee SA
    Appl Biochem Biotechnol; 2017 Aug; 182(4):1403-1414. PubMed ID: 28101786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurophysiological studies of minamata disease with HTLV-I associated myelopathy--a case report].
    Nakanishi R; Yamanaga H; Shido T; Imamura S; Izuno Y; Ideta T
    Rinsho Shinkeigaku; 1996 Sep; 36(9):1060-4. PubMed ID: 8976128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurological symptoms and disability in HTLV-1 associated myelopathy].
    Carod-Artal FJ; Mesquita HM; Ribeiro Lda S
    Neurologia; 2008 Mar; 23(2):78-84. PubMed ID: 18322825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon.
    Takatani M; Crispim ME; Fraiji N; Stefani MM; Kiesslich D
    Rev Inst Med Trop Sao Paulo; 2017 Apr; 59():e5. PubMed ID: 28380116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the vestibular evoked myogenic potential (VEMP) to identify subclinical neurological alterations in different phases of human T-lymphotropic virus type 1 infection.
    Felipe L; Kingma H; Lambertucci JR; Carneiro-Proietti AB; Gonçalves DU
    Spine J; 2013 Apr; 13(4):397-401. PubMed ID: 23267739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The current and future approaches to the treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Yamano Y; Sato T; Ando H; Araya N; Yagishita N
    Nihon Rinsho; 2012 Apr; 70(4):705-13. PubMed ID: 22568157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.